Product Information

METHYLPHENIDATE CD 50 MG CAP is a generic product labeled by Lannett Company Inc., priced at $1.4616 per EA under NDC 00527458337. Its NADAC has been published 386 times since Apr 3, 2019.

FDA first approved this application on Apr 3, 2001. Its Orange Book therapeutic-equivalence code is AB2 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

METHYLPHENIDATE CD 50 MG CAP

methylphenidate hydrochloride
$1.4616per EA
DEA Schedule CII

Strength

50 mg/1

NDC

00527458337

Classification

Generic

Dosage Form

CAPSULE, EXTENDED RELEASE

Route

ORAL

Effective Date

8/19/2026

Approval Type

Authorized Generic (NDA)

FDA Application

NDA021259

FDA Approved

4/3/2001

TE Code

AB2

On Market Since

3/21/2006

Pharmacological Classes

Central Nervous System Stimulant
Central Nervous System Stimulation

Price Statistics

The NADAC for METHYLPHENIDATE CD 50 MG CAP has been published 386 times since Apr 3, 2019, and over the history we have for it it has declined 67.2%. The table below summarizes its recorded NADAC range and movement.

Current price$1.4616 per EA
All-time high$4.4589 (Apr 10, 2019)
All-time low$1.1295 (May 22, 2024)
52-week high$2.0701
52-week low$1.4472
Median price$2.1491
Average price$2.3112
Largest weekly change+42.5% (Jan 19, 2022)
Weeks tracked386
Tracking sinceApr 3, 2019

Price History

1W

-2.6%

1M

-2.6%

3M

-3.4%

6M

+1.0%

1Y

-29.4%

3Y

-15.3%

5Y

-30.3%

All

-67.2%

Generic Alternatives

The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of METHYLPHENIDATE CD 50 MG CAP?

The current National Average Drug Acquisition Cost (NADAC) for METHYLPHENIDATE CD 50 MG CAP, manufactured by Lannett Company Inc., is $1.4616 per EA (NDC 00527458337), effective Aug 19, 2026.

How has the price of METHYLPHENIDATE CD 50 MG CAP changed over time?

Over the history we have for it, the NADAC for METHYLPHENIDATE CD 50 MG CAP has declined 67.2%. It has been tracked across 386 weekly CMS publications since Apr 3, 2019.

What are the highest and lowest recorded NADAC prices for METHYLPHENIDATE CD 50 MG CAP?

Since Apr 3, 2019, the NADAC for METHYLPHENIDATE CD 50 MG CAP has ranged from a low of $1.1295 (May 22, 2024) to a high of $4.4589 (Apr 10, 2019), with a median of $2.1491 per EA.

Are there cheaper alternatives to METHYLPHENIDATE CD 50 MG CAP?

3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as METHYLPHENIDATE CD 50 MG CAP in a comparable dosage form, but none are currently priced below it.

Who manufactures METHYLPHENIDATE CD 50 MG CAP?

METHYLPHENIDATE CD 50 MG CAP (NDC 00527458337) is labeled by Lannett Company Inc., and CMS classifies it as a generic product.